Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients

BACKGROUND: Epidermal growth factor receptor (EGFR) mutation analysis has become an important part of the initial workup of non-squamous non-small cell lung cancer (NS-NSCLC) patients as it is now recognized both as a prognostic and predictive marker to therapy with EGFR tyrosine kinase inhibitors (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kota, Rajesh, Gundeti, Sadashivudu, Gullipalli, Muralidhar, Linga, Vijay Gandhi, Maddali, Lakshmi Srinivas, Digumarti, Raghunadharao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663857/
https://www.ncbi.nlm.nih.gov/pubmed/26664160
http://dx.doi.org/10.4103/0970-2113.168099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663857/
https://www.ncbi.nlm.nih.gov/pubmed/26664160
http://dx.doi.org/10.4103/0970-2113.168099

Ejemplares similares